In Japan, the medical community is trying to figure out who is providing unnecessary care. This is a big deal because it affects how well patients are treated and how much healthcare costs. Most of the research on this topic has been done in the US. So, Japan is a bit of a mystery. First, let's
Japan's space ambitions have been on full display. A private Japanese company has been trying to make history by successfully landing a robotic spacecraft on the moon. This isn't their first attempt, but the outcome is still up in the air. The company, based in Tokyo, is part of a new wave of priva
Japan is determined to speed up the availability of new cancer treatments. These treatments offer better outcomes than existing options. To make this happen, countries use special pathways to quicken the approval process. This is known as expedited approval. A study compared the speed of drug ap
Adolescents with mental health issues often struggle with communication and social interaction. This is where virtual reality (VR) steps in. VR is becoming a popular tool in mental health care. It offers a safe and controlled environment for social interaction and therapy. In Japan, a unique tel
Asciminib is a drug that has been making waves in the treatment of chronic myeloid leukemia (CML). The ASC4FIRST study is a phase III trial that compared asciminib with other tyrosine kinase inhibitors (TKIs) chosen by doctors. The results were impressive, showing that asciminib was more effective
In a move to boost electric vehicle (EV) infrastructure, Japan is mulling over a new strategy. The plan? Offer financial help for setting up charging spots for Tesla cars. This is all part of ongoing trade talks with the United States. Right now, Japan gives money to help install charging points for
Japan's farm minister, Taku Eto, found himself in hot water after a joke about rice went awry. At a local event, he casually mentioned that he never had to buy rice because his supporters gifted him plenty. This comment sparked outrage, especially in a country grappling with a cost-of-living crisis.
Follicular lymphoma (FL) is a significant health issue in Japan, the United States, and Western Europe. It stands as the second most frequent type of non-Hodgkin lymphoma (NHL). Parsaclisib is a drug that targets a specific pathway in cancer cells. It has shown promise in earlier tests with patients
Japan is home to many older adults who live independently. A recent study looked into what makes these seniors feel good about their lives, even when they don't have many social activities. The study focused on a group of 1, 183 people aged 65 and above. The goal was to figure out what factors co
Japan's stock market had a thrilling day recently. Shares in many companies skyrocketed. Why? Because Toyota, the giant carmaker, announced a massive plan. They want to take their parts-making subsidiary, Toyota Industries, private. This move could be worth a staggering 42 billion dollars. It's a hu
